Gut microbiota and metabolomics unveil the mechanisms of Lomatogonium rotatum in ameliorating visceral fat and serum lipids in high-fat diet-induced obese mice

<i>Lomatogonium rotatum</i> (LR) is a folk medicinal herb traditionally used as a lipid-lowering and anti-obesity agent; but its pharmacological mechanism is unclear. In this study, we assessed the alterations of LR on gut microbes and serum metabolites in obese mice and their associated mechanisms of modulation on visceral fat and serum lipid by integrating gut microbiota and metabolomics analyses. Mice were fed a high-fat diet (HFD) to generate obesity and were then given LR and Orlistat orally at different doses (0.18, 0.9, 1.8 g/kg for LR and 0.048 g/kg for Orlistat) for a duration of 9 weeks. The impact of LR on weight loss was assessed through the examination of fat deposition, serum lipid indices, liver indices, and HE pathohistology. The effects of LR on gut microbiota and serum metabolites in obese mice were then investigated by 16S rRNA sequencing technology and untargeted metabolomics, and correlation analysis was performed. LR significantly reduced body weight, feed intake, Lee's index, visceral fat accumulation, serum TG, TC, AST and ALT, and elevated serum HDL levels in obese mice. In addition, 16S rRNA sequencing results indicated that the LR intervention remodeled microbial diversity and composition, increased the relative abundance of gut microbes <i>Bacteroidetes</i> and <i>Porphyromonadaceae</i> in HFD-induced obese mice, and decreased the <i>Deferribacteres</i>, <i>Firmicutes</i> and the <i>Firmicutes/Bacteroidetes</i> ratio. Correlation analyses showed that LR regulation of L-tyrosine and hesperetin metabolism, as well as alterations in the metabolic pathways of Phenylalanine, tyrosine and tryptophan biosynthesis, were associated with the changes in abundance of <i>Bacteroidetes</i>, <i>Firmicutes, Porphyromonadaceae</i> and <i>Deferribacteres</i>. Our study demonstrated that LR has lipid lowering and visceral fat reduction effects and its function may be closely related to the improvement of the gut microbiota and its associated metabolites.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2024-11-04
DOI
https://doi.org/10.3389/fphar.2024.1418063
Citations
5
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gut microbiota and metabolomics unveil the mechanisms of Lomatogonium rotatum in ameliorating visceral fat and serum lipids in high-fat diet-induced obese mice

Almaz Borjigidai, Laxinamujila Bai, Hongbo Wang, Xiaoping Ji et al.
5 citations
Frontiers in Pharmacology
Gut microbiota and health
1.17
article

Gut microbiota and metabolomics unveil the mechanisms of Lomatogonium rotatum in ameliorating visceral fat and serum lipids in high-fat diet-induced obese mice

Almaz Borjigidai, Laxinamujila Bai, Hongbo Wang, Xiaoping Ji, Galih Kusuma Aji, Xiaoman Li, Tianyu Si, Xuemei Bao, Minghai Fu, Liguo Wang, Hongzhen Yu
article en
5 citations

Abstract

<i>Lomatogonium rotatum</i> (LR) is a folk medicinal herb traditionally used as a lipid-lowering and anti-obesity agent; but its pharmacological mechanism is unclear. In this study, we assessed the alterations of LR on gut microbes and serum metabolites in obese mice and their associated mechanisms of modulation on visceral fat and serum lipid by integrating gut microbiota and metabolomics analyses. Mice were fed a high-fat diet (HFD) to generate obesity and were then given LR and Orlistat orally at different doses (0.18, 0.9, 1.8 g/kg for LR and 0.048 g/kg for Orlistat) for a duration of 9 weeks. The impact of LR on weight loss was assessed through the examination of fat deposition, serum lipid indices, liver indices, and HE pathohistology. The effects of LR on gut microbiota and serum metabolites in obese mice were then investigated by 16S rRNA sequencing technology and untargeted metabolomics, and correlation analysis was performed. LR significantly reduced body weight, feed intake, Lee's index, visceral fat accumulation, serum TG, TC, AST and ALT, and elevated serum HDL levels in obese mice. In addition, 16S rRNA sequencing results indicated that the LR intervention remodeled microbial diversity and composition, increased the relative abundance of gut microbes <i>Bacteroidetes</i> and <i>Porphyromonadaceae</i> in HFD-induced obese mice, and decreased the <i>Deferribacteres</i>, <i>Firmicutes</i> and the <i>Firmicutes/Bacteroidetes</i> ratio. Correlation analyses showed that LR regulation of L-tyrosine and hesperetin metabolism, as well as alterations in the metabolic pathways of Phenylalanine, tyrosine and tryptophan biosynthesis, were associated with the changes in abundance of <i>Bacteroidetes</i>, <i>Firmicutes, Porphyromonadaceae</i> and <i>Deferribacteres</i>. Our study demonstrated that LR has lipid lowering and visceral fat reduction effects and its function may be closely related to the improvement of the gut microbiota and its associated metabolites.

Frontiers in PharmacologyVol. 15
Minzu University of China (CN), Liaoning University of Traditional Chinese Medicine (CN), National Research and Innovation Agency (ID), Hainan Medical University (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 21%
Gut microbiota and health
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.